Browse > Article
http://dx.doi.org/10.4333/KPS.2009.39.5.359

Pharmacokinetic Behavior and Biodistribution of Paclitaxel-Loaded Lipid Nanosuspension  

Choi, Sung-Up (Division of Pharmaceutical Sciences, College of Pharmacy, Chung-Ang University)
Park, Jung-Min (Division of Pharmaceutical Sciences, College of Pharmacy, Chung-Ang University)
Choi, Woo-Sik (Division of Pharmaceutical Sciences, College of Pharmacy, Chung-Ang University)
Lee, Jae-Hwi (Division of Pharmaceutical Sciences, College of Pharmacy, Chung-Ang University)
Choi, Young-Wook (Division of Pharmaceutical Sciences, College of Pharmacy, Chung-Ang University)
Publication Information
Journal of Pharmaceutical Investigation / v.39, no.5, 2009 , pp. 359-366 More about this Journal
Abstract
In this study, paclitaxel-loaded lipid nanosuspension (PxLN) was prepared and the in vivo profiles after intravenous administration in rats were investigated. We compared the manufacturing processes depending on the temperature: PxLN-H for a hot homogenization process and PxLN-C for solidification of lipid-drug mixtures by liquid nitrogen. Both formulations showed submicron size distribution and the similar drug loading efficiency of about 70%. In vitro release of PxLNs and Taxol$^{(R)}$ performed by a dialysis diffusion method showed similar pattern for PxLN-H and Taxol$^{(R)}$, but the reduced release profile for PxLN-C. PxLN or Taxol$^{(R)}$ was intravenously administered to the rats at a dose of 5 mg/kg as paclitaxel. The drug in blood samples were assayed by the HPLC/MS/MS method. The AUC$_t$ of PxLN-H was 3.4-fold greater than that of Taxol$^{(R)}$. PxLN-H gave higher biodistribution in all tissues than did Taxol$^{(R)}$. In addition, it maintained the higher drug concentration for 12 h. This lipid nanosuspension might be a promising candidate for an alternative formulation for the parenteral delivery of poorly water-soluble paclitaxel.
Keywords
Paclitaxel; Lipid Nanosuspension; Pharmacokinetic Behavior; Biodistribution;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 H. Heiati, R. Tawashi and N.C. Phillips, Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization, J. Microencapsul., 15, 173-184 (1998).   DOI
2 W.R. Perkins, I. Ahmad, X. Li, D.J. Hirsh, G.R. Masters, C.J. Fecko, J. Lee, S. Ali, J. Nguyen, J. Schupsky, C. Herbert, A.S. Janoff and E. Mayhew, Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds, Int. J. Pharm., 200, 27-39 (2000).   DOI   ScienceOn
3 R. Cavalli, O. Caputo and M.R. Gasco, Preparation and characterization of solid lipid nanospheres containing paclitaxel, Eur. J. Pharm. Sci., 10, 305-309 (2000).   DOI   ScienceOn
4 S.C. Yang, L.F. Lu, Y. Cai, J.B. Zhu, B.W. Liang and C.Z. Yang, Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain, J. Controlled Rel., 59, 299-307 (1999).   DOI   ScienceOn
5 C.M. Spencer and D. Faulds, Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer, Drugs, 48, 794-847 (1994).   DOI   ScienceOn
6 G.J. Fetterly and R.M. Straubinger, Pharmacokinetics of paclitaxel-containing liposomes in rats, AAPS Pharm. Sci., 5, E32 (2003).   DOI   ScienceOn
7 G. Basileo, M. Breda, G. Fonte, R. Pisano and C.A. James, Quantitative determination of paclitaxel in human plasma using semi-automated liquid-liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry, J. Pharm. Biomed. Anal., 32, 591-600 (2003).   DOI   ScienceOn
8 R.H. Muller, K. Mader and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art, Eur. J. Pharm. Biopharm., 50, 161-177 (2000).   DOI   ScienceOn
9 B. Sjostrom and B. Bergenstahl, Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate, Int. J. Pharm., 88, 53-62 (1992).   DOI   ScienceOn
10 J.A. Shabbits, G.N. Chiu and L.D. Mayer, Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems, J. Controlled Rel., 84, 161-170 (2002).   DOI   ScienceOn
11 K. Westesen, H. Bunjes and M.H. Koch, Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential, J. Controlled Rel., 48, 223-236 (1997).   DOI   ScienceOn
12 L. Serpe, M.G. Catalano, R. Cavalli, E. Ugazio, O. Bosco, R. Canaparo, E. Muntoni, R. Frairia, M.R. Gasco, M. Eandi and G.P. Zara, Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line, Eur. J. Pharm. Biopharm., 58, 673-680 (2004).   DOI   ScienceOn
13 J. Hamdani, A.J. Moes and K. Amighi, Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets, Int. J. Pharm., 260, 47-57 (2003).   DOI   ScienceOn
14 J. Liu, F. Zhang and J.W. McGinity, Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion, Eur. J. Pharm. Biopharm., 52, 181-190 (2001).   DOI   ScienceOn
15 J.A. Straub, D.E. Chickering, J.C. Lovely, H. Zhang, B. Shah, W.R. Waud and H. Bernstein, Intravenous hydrophobic drug delivery: a porous particle formulation of paclitaxel (AI-850), Pharm. Res., 22, 347-355 (2005).   DOI
16 D.B. Chen, T.Z. Yang, W.L. Lu and Q. Zhang, In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel, Chem. Pharm. Bull. (Tokyo), 49, 1444-1447 (2001).   DOI   ScienceOn
17 A. Miglietta, R. Cavalli, C. Bocca, L. Gabriel and M.R. Gasco, Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel, Int. J. Pharm., 210, 61-67 (2000).   DOI   ScienceOn
18 S.U. Choi, S.K. Kim, J.M. Lee and Y.W. Choi, Injection Formulation of Paclitaxel Employing Solid Lipid Nanoparticles (SLN), J. Kor. Pharm. Sci., 33, 319-322 (2003).   과학기술학회마을
19 W. Mehnert and K. Mader, Solid lipid nanoparticles: production, characterization and applications, Adv. Drug Del. Rev., 47, 165-196 (2001).   DOI   ScienceOn
20 A.L. Almeida, S. Runge and R.H. Muller, Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters, Int. J. Pharm., 149, 255-265 (1997).   DOI   ScienceOn
21 M.R. Wenk, A. Fahr, R. Reszka and J. Seelig, Paclitaxel partitioning into lipid bilayers, J. Pharm. Sci., 85, 228-231 (1996).   DOI